Molina Healthcare's Medicaid medical cost ratio ran 92.7% in the second quarter of 2026, up from 91.3% a year earlier, with Medicare at 90.7% and Marketplace at 88.9%, pushing the consolidated ratio to 92.2% (Molina, July 22, 2026).
The company raised full-year adjusted guidance to at least $5.25 per diluted share, and CEO Joseph Zubretsky called 2026 the trough year for Medicaid margins. What he described stabilizing is the gap, not the ratio.
Key Takeaways
- Medicaid deteriorated 140 basis points to 92.7% and management still called it in line with expectation, because Medicaid capitation is set on a historical base period that predates the acuity shift running through it.
- Marketplace slid 350 basis points to 88.9% on prior-year risk adjustment, program integrity initiatives and unfavorable acuity mix, and a $1.50 per-share Medicare gain is offset almost exactly by a $1.50 per-share Marketplace loss.
- 69% of unwinding-era disenrollments were procedural, falling on healthier members least motivated to complete renewal paperwork, which is the selection channel that raises the cost of everyone who stays.
- Six-month redeterminations for expansion adults begin December 31, 2026, doubling the frequency of that selection while mid-period rate adjustments are capped at 1% before full re-certification.
- Half-year adjusted EPS of $3.86 trails $11.56 in the first half of 2025, so trough here means a genuinely compressed earnings base rather than a modest dip.
Three Segments, Three Directions
Adjusted earnings per share of $1.51 beat the $1.40 consensus by eight cents, on $10.9 billion of total revenue and $10.2 billion of premium revenue, itself down 6% as membership contracted. Six months in, adjusted EPS of $3.86 trails the $11.56 booked in the first half of 2025.
| Segment | Q2 2026 MCR | Q2 2025 MCR | Change | Membership (June 30, 2026) |
|---|---|---|---|---|
| Medicaid | 92.7% | 91.3% | +140 bps | 4.418 million |
| Medicare | 90.7% | 90.0% | +70 bps | 224,000 |
| Marketplace | 88.9% | 85.4% | +350 bps | 283,000 |
| Consolidated | 92.2% | 90.4% | +180 bps | 4.926 million |
Management called the Medicaid print "in line with the Company's expectation," the Medicare print "better than the Company's expectation," and the Marketplace print "higher than the Company's expectations." Marketplace moved 350 basis points to 88.9% from 85.4%, and it is the segment that surprised Molina's own model.
A Medicaid ratio that is in line at 92.7%, worse than a year ago, reads oddly as an input to a trough call, and the reason is rate timing. Medicaid capitation is set once or twice a year by state agencies and certified under 42 CFR 438.4's actuarial soundness framework on a historical base period, so the rate a state pays in mid-2026 was built on cost data preceding the redetermination-driven acuity shift and the elevated behavioral health and specialty pharmacy utilization running through managed care since 2024.
"The imbalance between Medicaid rates and medical cost trend appears to have stabilized and is well positioned to be corrected with future rate increases," Zubretsky said. Two lines converging is a materially weaker claim than a gap already closed, and it is what the trough framing rests on.
Where the Guidance Actually Nets Out
Marketplace's slide stacks three distinct drags in one disclosure: "prior year risk adjustment and program integrity initiatives and the impact of current year unfavorable member acuity mix." The first means the 2025 accident-year ACA risk-transfer receivable came in below what was booked, a true-up flowing through the current period even though the claims experience is a year old.
The second and third are the same mechanism seen twice. CMS's tightened verification of subsidy eligibility removes marginal enrollees from exchange rolls, and the members stricter verification catches tend to be lower utilizers who enrolled opportunistically rather than sicker members who worked to stay covered. A shrinking, more adversely selected book raises average cost per remaining member with no change in underlying trend.
The guidance bridge sizes the surprise. A $1.50 per-share increase from better-than-expected Medicare performance is offset almost exactly by a $1.50 per-share decrease in Marketplace, a dollar-for-dollar swap inside an otherwise unchanged outlook.
Medicare is the segment where Molina's own pricing did the work, reflecting "lower medical cost trend and pricing implemented for 2026," consistent with the sector-wide Medicare Advantage repricing that followed the 2024 to 2025 cost shock. It is not free. Guidance embeds a $1.00 per-share loss on the traditional MAPD product Molina will exit for 2027, plus a separate $1.50 per-share loss on the new Florida Medicaid contract beginning in the fourth quarter of 2026.
Both sit inside the "at least $5.25," and both concentrate in the two places where near-term losses are hardest to size at certification: a product being wound down and a state contract still ramping.
The Acuity Clock Runs Faster Than the Rate Clock
The risk to the trough thesis is not trend accelerating further. It is the composition of Molina's own 4.418 million Medicaid members shifting in a direction the certified rates did not anticipate.
Redetermination removals are not random. KFF's tracker found 69% of disenrollments during the 2023 to 2024 unwinding were procedural, meaning coverage lost over paperwork rather than a finding of ineligibility, and procedural disenrollment falls hardest on younger, healthier enrollees least motivated to renew coverage they rarely use. As the healthier share churns off faster, the remaining members skew costlier, and that drift reaches claims experience well before the next rate-setting cycle can reflect it.
The regulatory lag makes it worse. A rate certified under 42 CFR 438.4 for a twelve-month period embeds a morbidity assumption as of the certification date, and mid-period adjustments are capped at 1% before full re-certification, which adds months (mid-cycle capitation repricing). The One Big Beautiful Bill Act's move to six-month redeterminations for expansion adults, beginning December 31, 2026, doubles the frequency of exactly the selection that produced the 69% figure, while states absorb roughly $840 billion of ten-year Medicaid spending reductions.
The peer prints show two different routes to the same word. Elevance's benefit expense ratio rose to 89.7% with full-year Medicaid segment operating margin expected at negative 1.75%, and CEO Gail Boudreaux confirmed exits from additional Medicaid markets over 12 to 18 months (InsuranceNewsNet). UnitedHealth's ratio fell 270 basis points to 86.7%, helped by shedding 380,000 Medicaid members through a planned Louisiana exit (Fierce Healthcare).
Shrinking out of the worst-performing geography is a different claim than holding share and waiting for state rate-setters to catch up. Molina has announced no comparable exits and is calling its trough while carrying the full 4.418 million members whose acuity mix is the open variable.
The timing also costs Molina something at the table. States are setting 2027 capitation under the CMS 2026-2027 rate development guide, and MCOs and states negotiate certified rates adversarially inside the soundness framework. A national Medicaid MCO raising guidance and calling the margin environment a trough about to improve hands state reviewers the argument that the rate-to-trend gap is closing without a rate action as large as the MCO's own actuaries would request.
Further Reading
- Centene's Q2 2026 Marketplace Risk-Adjustment Swing: How a shrinking, purge-driven Marketplace book pushed Centene's risk-adjustment position favorable, a different funding mechanism than Medicaid's state-set capitation rates.
- UnitedHealth and Elevance's Q2 2026 Managed-Care Divergence: The pricing and reserving mechanics behind UnitedHealth's 86.7% MBR and Elevance's 89.7% benefit expense ratio.
- Aetna's 250bp MBR Drop Rode a $471M Reserve Reversal: The Medicare Advantage counterpart to Molina's Medicaid MCR story, where reserve release and a lapsed deficiency charge, not acuity mix, are the swing factors.
- OBBBA's Mid-Cycle Medicaid Capitation Repricing Problem: Why certified rates under 42 CFR 438.4 cannot easily absorb a statutory shock mid-rating-period.
- Medicaid Six-Month Redetermination and the Managed-Care Actuarial Fallout: The procedural-disenrollment and acuity-mix dynamics driving the risk to Molina's trough call.
- Medicaid Work Requirements and 2027 Capitation Rate Assumptions: How the next eligibility policy wave feeds the same rate cycle Molina's 2027 advocacy depends on.
- CMS's 2026-2027 Medicaid Rate Development Guide: The certification framework state actuaries are applying to the rate increases Molina's guidance assumes.
Sources
- Molina Healthcare Reports Second Quarter 2026 Financial Results (BusinessWire, via Morningstar) (July 22, 2026)
- Molina Healthcare Reports Second Quarter 2026 Financial Results (Yahoo Finance) (July 22, 2026)
- Fierce Healthcare: Cost Pressures Limit Molina Healthcare During Q2 Earnings as Stock Dips (July 2026)
- ChartMill: Molina Healthcare Surprises on Q2 Earnings, Raises Guidance as Quality Stock Nears Trough in Medicaid Cycle (July 2026)
- InsuranceNewsNet: Elevance Hikes 2026 Outlook Off Strong Q2, to Exit More Medicaid Markets (July 2026)
- Fierce Healthcare: UnitedHealth Group Boosts Outlook as It Posts $5.5B Q2 Profit (July 2026)
- CMS, 2026-2027 Medicaid Managed Care Rate Development Guide (February 2026)
- KFF Medicaid Enrollment and Unwinding Tracker